Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of UDCA and ezetimibe on faecal sterol excretion and plasma lipids in familial hypercholesterolemia
2016-003281-84Phase 4Active
- Sponsor
- Amsterdam UMC
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, ursodeoxycholic acid in familial hypercholesterolemia (FH), sponsored by Amsterdam UMC. Started Dec 2016; status: active.
02
Drugs
ezetimibeursodeoxycholic acid
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on 2016-003281-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003281-84.